期刊文献+

FBN1、FBN2基因甲基化与食管癌的相关性研究 被引量:4

Study on the correlation between FBN1/FBN2 gene methylation and esophageal carcinoma
下载PDF
导出
摘要 目的:研究食管癌组织原纤蛋白-1(Fibrillin-1,FBN1)与原纤蛋白-2(Fibrillin-2,FBN2)基因启动子区的甲基化状态,进一步探讨FBN1、FBN2基因甲基化与食管癌的相关性,为研究肿瘤的发生发展等提供一定的理论基础。方法:采用甲基化特异性PCR(methylation special PCR,MSP)检测方法,检测95例食管癌组织标本、癌旁组织标本的FBN1、FBN2基因启动子区甲基化状态。采用Western blot检测肿瘤组织的蛋白含量,并分析蛋白表达与基因的相关性。结果:食管癌组织和癌旁组织中FBN1基因甲基化发生率分别为86.3%(82/95)和5.3%(5/95);FBN2基因甲基化发生率分别为82.1%(78/95)和8.4%(8/95),差异均具有统计学意义(P<0.001)。根据分化程度、TNM分期、性别等对患者进行分组,各组之间均无明显差异(P>0.05)。Western blot检测结果提示基因甲基化明显影响蛋白表达,使蛋白表达量明显减少。结论 :FBN1、FBN2基因甲基化与食管癌的发生发展具有十分密切的关系,该基因可以作为一种潜在的抑癌基因,对研究食管癌的发病机制及治疗提供潜在的理论基础。 Objective:This paper tested the Fibrillin-1(FBN1) and Fibrillin-2(FBN2) gene promoter methylation status in tumor tissue of esophageal cancer patients,to further explore the relationship between the methylation of these genes and esophageal cancer,to provide a theoretical basis for the study of tumor development.Methods:Methylation specific PCR(MSP) detection method was used to detect the methylation status of FBN1 and FBN2 gene promoter in 95 cases of esophageal cancer tissues and adjacent tissues specimens.Results:The methylation rate of FBN1 gene in esophageal cancer tissues and adjacent tissues were 86.3%(82/95) and 5.3%(5/95).The rates of FBN2 gene methylation were 82.1%(78/95) and 8.4%(8/95),the difference was statistically significant(P〈0.001).And the patients were divided into groups according to the degree of differentiation,TNM stage,gender and so on,there was no significant difference between the groups(P〉0.05).Conclusion:There is a very close relationship between the methylation of FBN1/FBN2 gene and esophageal cancer.The gene can be used as a potential tumor suppressor gene,and this study may provide a theoretical basis for the potential pathogenesis and treatment of esophageal cancer.
出处 《现代肿瘤医学》 CAS 2018年第4期523-526,共4页 Journal of Modern Oncology
关键词 食管癌 FBN1 FBN2 基因 甲基化 esophageal cancer, FBN1, FBN2, gene, methylation
  • 相关文献

参考文献1

二级参考文献14

  • 1Marsit CJ,Liu M,Nelson HH,et al. Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers:implications for treatment and survival[J]. Oncogene,2004;23(4):1000-1004.
  • 2Gazdar AF,Miyajima K,Reddy J,et al. Molecular targets for cancer therapy and prevention[J]. Chest,2004;125(5 Suppl):97S-101S.
  • 3Zochbauer-Muller S,Minna JD,Gazdar AF, Aberrant DNA methylation in lung cancer:biological and clinical implications[J]. Oncologist, 2002; 7 ( 5 ) : 451-457,
  • 4Hagihara A,Miyamoto K,Furuta J,et al, Identification of 27 5' CpG islands aberrantly methylated and 13 genes silenced in human pancreatic cancers[J]. Oncogene, 2004; 23 (53) : 8705-8710.
  • 5Chomczynski P,Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction[J]. Anal Biochem, 1987; 162( 1 ): 156-159.
  • 6Herrmann BG,Frischauf AM. Isolation of genomic DNA [J]. Methods Enzymol, 1987; 152:180-183,
  • 7Yang Q,Ota K,Tian Y,et al. Cloning of rat fibrillin-2 cDNA and its role in branching morphogenesis of embryonic lung[J]. Dev Biol, 1999 ; 212 ( 1 ) : 229-242.
  • 8Suzuki M,Iizasa T,Fujisawa T,et al. Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in non-small-cell lung cancer [J]. Invasion Metastasis, 1998, 18 (3) : 134-141.
  • 9Kim DH,Nelson HH,Wiencke JK,et al. Promoter methylation of DAP-kinase:association with advanced stage in non-small cell lung cancer[J]. Oncogene,2001 ;20(14) : 1765-1770.
  • 10Virmani AK,Rathi A,Z?chbauer-M u ller S,et al. Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas[J]. J Natl Cancer Inst,2000;92:1303-1307.

同被引文献29

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部